| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ascelia Pharma AB (publ) (ST: ACE)
ACE Technical Analysis
5
| As on 31st Mar 2025 ACE STOCK Price closed @ 2.83 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.53 & Strong Sell for SHORT-TERM with Stoploss of 3.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACESTOCK Price
| Open | 2.90 | Change | Price | % |
| High | 2.90 | 1 Day | -0.09 | -3.08 |
| Low | 2.81 | 1 Week | -0.39 | -12.11 |
| Close | 2.83 | 1 Month | -0.47 | -14.24 |
| Volume | 262144 | 1 Year | -0.73 | -20.51 |
| 52 Week High 13.90 | 52 Week Low 2.04 | ||||
ST Sweden Most Active Stocks
| ATORX | 0.01 | 0.00% |
| QUIA | 0.01 | % |
| FING-B | 0.01 | 0.00% |
| QLINEA | 0.04 | 0.00% |
| FNOX | 86.98 | 33.65% |
| WYLD | 0.03 | 0.00% |
| SBB-B | 3.38 | -2.87% |
| LUNE | 21.97 | 6.65% |
| TELIA | 36.29 | 0.69% |
| XBRANE | 0.21 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| ACE Daily Charts |
ACE Intraday Charts |
Whats New @ Bazaartrend |
ACE Free Analysis |
|
|
ACE Important Levels Intraday
| RESISTANCE | 3.00 |
| RESISTANCE | 2.95 |
| RESISTANCE | 2.91 |
| RESISTANCE | 2.88 |
| SUPPORT | 2.78 |
| SUPPORT | 2.75 |
| SUPPORT | 2.71 |
| SUPPORT | 2.66 |
ACE Forecast April 2025
| 4th UP Forecast | 4.97 |
| 3rd UP Forecast | 4.28 |
| 2nd UP Forecast | 3.86 |
| 1st UP Forecast | 3.43 |
| 1st DOWN Forecast | 2.23 |
| 2nd DOWN Forecast | 1.8 |
| 3rd DOWN Forecast | 1.38 |
| 4th DOWN Forecast | 0.69 |
ACE Weekly Forecast
| 4th UP Forecast | 4.97 |
| 3rd UP Forecast | 4.28 |
| 2nd UP Forecast | 3.86 |
| 1st UP Forecast | 3.43 |
| 1st DOWN Forecast | 2.23 |
| 2nd DOWN Forecast | 1.80 |
| 3rd DOWN Forecast | 1.38 |
| 4th DOWN Forecast | 0.69 |
ACE Forecast2025
| 4th UP Forecast | 33.62 |
| 3rd UP Forecast | 23.75 |
| 2nd UP Forecast | 17.64 |
| 1st UP Forecast | 11.54 |
| 1st DOWN Forecast | -5.88 |
| 2nd DOWN Forecast | -11.98 |
| 3rd DOWN Forecast | -18.09 |
| 4th DOWN Forecast | -27.96 |
Ascelia Pharma AB (publ) ( ST Sweden Symbol : ACE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACE Business Profile
Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer. Ascelia Pharma has a clinical collaboration agreement with Taiho Oncology, Inc. for the development of Oncoral in combination with LONSURF. The company was founded in 2000 and is headquartered in Malmö, Sweden. Address: Hyllie Boulevard 34, Malmö, Sweden, 215 32
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service